Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study

Publisher： Karger

E-ISSN： 2296-5262|37|1-2|24-28

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.1-2, 2014-01, pp. : 24-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 359-365

Karger

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

By  

Oncology Research and Treatment, Vol. 26, Iss. 3, 2003-07 ,pp. : 255-258

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Leucovorin and Oxaliplatin plus Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer: A Single-Institute Study

By  

Oncology, Vol. 72, Iss. 1-2, 2007-10 ,pp. : 4-9

Karger

Access to resources Recommend Favorite

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 104-113

Karger

Access to resources Recommend Favorite

Gemcitabine plus Paclitaxel as First-Line Chemotherapy for Patients with Advanced Breast Cancer

By  

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 18-23

Karger

Access to resources Recommend Favorite